In vitro susceptibility of Prototheca zopfii genotypes 1 and 2

29Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Prototheca zopfii causes bovine mastitis that leads to reduced milk production. Since P. zopfii isolates from mastitis have been assigned P. zopfii genotype 2, it suggests that this genotype is the etiologic agent of the infection. However, isolates of P. zopfii have not been investigated with regard to their in vitro drug susceptibility. In this study, we examine the susceptibility of genotype 2 strains from bovine mastitis and genotype 1 isolates recovered from cow-barn surroundings. The in vitro susceptibility of ten isolates and the type strain (SAG2063T) of P. zopfii genotype 1, and equal number of genotype 2 isolates and the type strain (SAG2021 T) were assessed by E-test against amphotericin B (AMB), gentamicin (GM), kanamycin (KM) and itraconazole (ITZ). Results showed that P. zopfii genotype 1 isolates are more susceptible in vitro to AMB, GM and KM than those of genotype 2. Moreover, genotype 2 isolates and seven isolates of genotype 1, including the type strain, are not susceptible to ITZ (>10 μg/ml). Thus, drug susceptibility of P. zopfii differs between these two genotypes. © 2011 ISHAM.

Cite

CITATION STYLE

APA

Sobukawa, H., Kano, R., Ito, T., Onozaki, M., Makimura, K., Hasegawa, A., & Kamata, H. (2011). In vitro susceptibility of Prototheca zopfii genotypes 1 and 2. Medical Mycology, 49(2), 222–224. https://doi.org/10.3109/13693786.2010.511285

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free